Stages of Glioma (Glial Tumor)
Table of Contents
Glioma (glial tumor) is a type of tumor that develops from glial cells, the supportive cells of the brain. These cells protect neurons, provide nutrients, and regulate communication within the nervous system. However, when they begin to multiply uncontrollably, they can form a mass in the brain and cause serious neurological problems.
Prof. Dr. Ömür Günaldı emphasizes that gliomas are not a single type of tumor but consist of many different subtypes and stages (grade system). These stages play a crucial role in determining the course of the disease and the treatment plan.
What Is Glioma Grading?
The World Health Organization (WHO) classifies gliomas into four grades (Grade I–IV) based on cell structure, growth rate, and tendency to spread.
This classification helps determine whether the tumor is benign or malignant.
Prof. Dr. Ömür Günaldı explains that grading should not rely solely on microscopic examination but should also include genetic analyses, since two tumors that look similar under the microscope may behave very differently at the molecular level.
Grade I – Low-Grade and Benign Gliomas
Grade I gliomas are generally considered benign tumors. In these tumors, cells multiply very slowly and usually do not spread to surrounding brain tissue.
One of the most common subtypes is pilocytic astrocytoma, which is often seen in children and young adults.
Prof. Dr. Ömür Günaldı states that surgical removal of the tumor is usually sufficient in Grade I gliomas and that many patients can live healthy lives for many years after treatment.
Radiotherapy or chemotherapy is usually not required at this stage.
Key Characteristics
- Slow growth
- Clear tumor boundaries
- Often completely removable with surgery
- Low risk of recurrence
Grade II – Low-Grade Gliomas With Risk of Progression
Grade II gliomas are also considered low-grade tumors, but they have the potential to progress to higher stages over time.
Cells multiply slightly faster than normal, and the tumor may spread minimally into surrounding tissue.
These tumors are often low-grade astrocytomas or oligodendrogliomas.
Prof. Dr. Ömür Günaldı explains that surgery is the primary treatment in Grade II gliomas, but if the tumor cannot be completely removed, radiotherapy or chemotherapy may be recommended.
Key Characteristics
- Moderate growth rate
- Limited spread into surrounding tissue
- Risk of transformation to Grade III or IV
- Regular MRI monitoring is required
Patients treated at an early stage may live up to 10 years or longer.
Grade III – High-Grade and Aggressive Gliomas
Grade III gliomas are malignant tumors. Their cells are abnormal, grow rapidly, and tend to invade surrounding brain tissue.
The most common tumor type at this stage is anaplastic astrocytoma.
Prof. Dr. Ömür Günaldı states that surgery alone is not sufficient in Grade III gliomas and that combining radiotherapy and chemotherapy significantly improves survival.
Symptoms are often more noticeable at this stage and may include headaches, seizures, balance problems, speech disorders, or memory loss.
Key Characteristics
- Rapid tumor growth
- Spread into surrounding brain tissue
- Additional treatment required after surgery
- High recurrence risk
Prof. Dr. Ömür Günaldı explains that early diagnosis can extend survival up to 3–5 years.
Grade IV – Glioblastoma Multiforme (GBM)
Grade IV glioma is the most aggressive and malignant type of brain tumor. It is known medically as glioblastoma multiforme (GBM).
These tumors grow very rapidly, invade surrounding brain tissue, and often recur despite treatment.
Prof. Dr. Ömür Günaldı states that the standard treatment for glioblastoma includes surgery followed by radiotherapy and chemotherapy.
Genetic factors such as MGMT methylation may influence the response to treatment.
Key Characteristics
- Extremely rapid growth
- Invasion of surrounding brain tissue
- Cells resistant to treatment
- High recurrence rate
- Average survival of 12–24 months
However, early diagnosis, extensive surgical removal, and personalized treatment approaches may extend survival.
Life Expectancy and Prognosis by Stage
As the grade of glioma increases, the disease tends to progress more aggressively and the response to treatment becomes shorter.
However, Prof. Dr. Ömür Günaldı explains that advances in modern neurosurgical techniques, radiotherapy planning, and molecular therapies are improving survival outcomes each year.
Average Survival Estimates
Grade I: 15 years or more
Grade II: 8–12 years
Grade III: 3–5 years
Grade IV (GBM): 1–2 years
These are average values. The patient’s age, tumor genetics, and response to treatment all influence prognosis.
Importance of Early Diagnosis
Early diagnosis is one of the most important factors in glioma treatment.
Symptoms such as headaches, vision loss, speech difficulties, or seizures should not be ignored.
Prof. Dr. Ömür Günaldı emphasizes that early brain MRI can significantly improve both survival and quality of life.
When detected early, some gliomas can be completely removed surgically, allowing patients to live many healthy years.
The stages of glioma (glial tumor) are the most important criteria for understanding the biological behavior of the tumor.
Low-grade gliomas often behave more benignly and allow long-term survival, while high-grade gliomas progress more aggressively and require intensive treatment.
With extensive experience in neurosurgery, Prof. Dr. Ömür Günaldı emphasizes that staging is not only a diagnostic tool but also a critical factor in determining the most effective treatment strategy.
Through early diagnosis, precise surgical planning, and multidisciplinary treatment, many glioma patients today can achieve a longer and better quality of life.